A Phase II Study of Dacarbazine, Cisplatin, Interferon- and High-dose Interleukin-2 in 'Poor-risk' Metastatic Melanoma

By Proebstle T.M.   Scheibenbogen C.   Sterry W.   Keilholz U.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1530-1533

Elsevier

Access to resources Recommend Favorite

Phase II Study of Weekly High-dose Cisplatin for Six Cycles in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

By Planting A.S.T.   de Mulder P.H.M.   de Graeff A.   Verweij J.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 61-65

Elsevier

Access to resources Recommend Favorite

Long-Term Survival in Metastatic Melanoma Patients Treated with Sequential Biochemotherapy: Report of a Phase II Study

By Neri B.   Vannozzi L.   Fulignati C.   Pantaleo P.   Pantalone D.   Paoletti C.   Perfetto F.   Turrini M.   Mazzanti R.  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 474-478

Informa Healthcare

Access to resources Recommend Favorite

Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer - results of the EORTC 08912 phase I/II study

By Uitterhoeve A.L.J.   Belderbos J.S.A.   Koolen M.G.J.   van der Vaart P.J.M.   Rodrigus P.T.R.   Benraadt J.   Koning C.C.M.   Gonzalez Gonzalez D.   Bartelink H.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 592-600

Elsevier

Access to resources Recommend Favorite

Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan

By Kudawara Ikuo  

Journal of Chemotherapy, Vol. 25, Iss. 1, 2013-02 ,pp. : 41-48

Maney Publishing

Access to resources Recommend Favorite